The Target Advancement Program promotes work through two funding opportunities: Target Validation Awards and Target Optimization Awards.
Target Validation Awards are one-year grants to support research characterising promising, novel, PD-relevant targets or addressing critical remaining validation questions on established PD targets.
Target Optimization Awards are two-year grants to validate targets within MJFF-defined topic areas.
For the current round, MJFF invites projects designed to probe the therapeutic potential of targeting mechanisms of dystonia associated with PD.
Funding & Duration
- Target Validation Awards support one-year grants up to US $100,000 (approx. AUD $131,500)
- Optimization Awards support two-year grants up to $200,000 (approx. AUD $263,000)
Applications may be submitted by:
- U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held; and
- U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
Post-doctoral fellows are eligible to apply as principal investigator (PI) to the Target Validation Awards Program only, and must collaborate with an administrative PI who directs the laboratory in which the fellow will conduct research.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 12 October 2017
- Please complete your RFR through ResearchMaster and when prompted to Select Fund Scheme use Fund Scheme code 9999 (Other)
- Submit an Application to Research Services for Review